Loading...
•
Dec 31, 2022
agilon health Q4 2022 Earnings Report
agilon health reported Q4 2022 earnings with revenue increasing by 49% and Medicare Advantage membership increasing by 45%.
Key Takeaways
agilon health's Q4 2022 results showed strong growth with a 49% increase in revenue to $690 million and a 45% increase in Medicare Advantage membership to 269,500. The medical margin also saw a significant increase of 93% to $61 million.
Total revenue increased 49% to $690 million compared to Q4 2021.
Medicare Advantage membership increased 45% year-over-year.
Medical margin increased 93% to $61 million compared to Q4 2021.
Net loss was $57 million, consistent with Q4 2021.
Revenue by Segment
Forward Guidance
Agilon health provided guidance for the first quarter and full year 2023, including expectations for Medicare Advantage members, ACO REACH members, total members live on platform, total revenues, medical margin, and Adjusted EBITDA.
Positive Outlook
- Medicare Advantage Members are expected to be between 385,000 and 390,000 for Q1 2023 and between 400,000 and 410,000 for FY 2023.
- Total revenues are expected to be between $1,070 million and $1,090 million for Q1 2023 and between $4,280 million and $4,370 million for FY 2023.
- Medical Margin is expected to be between $160 million and $170 million for Q1 2023 and between $535 million and $560 million for FY 2023.
- Adjusted EBITDA is expected to be between $32 million and $37 million for Q1 2023 and between $75 million and $90 million for FY 2023.
- ACO REACH Members are expected to be between 85,000 and 90,000 for Q1 2023 and FY 2023.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...